Investigation of Antileishmanial Activities of Acridines Derivatives against Promastigotes and Amastigotes Form of Parasites Using Quantitative Structure Activity Relationship Analysis
暂无分享,去创建一个
Samir Chtita | Mohammed Bouachrine | Tahar Lakhlifi | Mounir Ghamali | B. Elidrissi | B. Elidrissi | M. Bouachrine | Samir CHTITA | T. Lakhlifi | M. Ghamali | Rachid Hmamouchi | Mohamed Bourass | Majdouline Larif | R. Hmamouchi | M. Larif | M. Bourass
[1] Paola Gramatica,et al. Principles of QSAR models validation: internal and external , 2007 .
[2] Walter D. Fisher. On Grouping for Maximum Homogeneity , 1958 .
[3] M. Wainwright,et al. Acridine-a neglected antibacterial chromophore. , 2001, The Journal of antimicrobial chemotherapy.
[4] V. Yardley,et al. Structure-activity relationships for the antileishmanial and antitrypanosomal activities of 1'-substituted 9-anilinoacridines. , 1997, Journal of medicinal chemistry.
[5] M. Bouachrine,et al. QSPR studies of 9-aniliioacridine derivatives for their DNA drug binding properties based on density functional theory using statistical methods: Model, validation and influencing factors , 2016 .
[6] M. Bouachrine,et al. Quantitative structure–activity relationship studies of dibenzo[a,d]cycloalkenimine derivatives for non-competitive antagonists of N-methyl-d-aspartate based on density functional theory with electronic and topological descriptors , 2015 .
[7] S. So,et al. Application of neural networks: quantitative structure-activity relationships of the derivatives of 2,4-diamino-5-(substituted-benzyl)pyrimidines as DHFR inhibitors. , 1992, Journal of medicinal chemistry.
[8] R. Davidson,et al. Emergence or re-emergence of visceral leishmaniasis in areas of Somalia, north-eastern Kenya, and south-eastern Ethiopia in 2000-01. , 2003, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[9] A. Basu,et al. Indolylquinoline derivatives are cytotoxic to Leishmania donovani promastigotes and amastigotes in vitro and are effective in treating murine visceral leishmaniasis. , 1999, The Journal of antimicrobial chemotherapy.
[10] T. A. Andrea,et al. Applications of neural networks in quantitative structure-activity relationships of dihydrofolate reductase inhibitors. , 1991, Journal of medicinal chemistry.
[11] Supratik Kar,et al. On a simple approach for determining applicability domain of QSAR models , 2015 .
[12] F. Charmantray,et al. Interest of acridine derivatives in the anticancer chemotherapy. , 2001, Current pharmaceutical design.
[13] D. Gérard,et al. Synthesis and antileishmanial activities of 4,5-di-substituted acridines as compared to their 4-mono-substituted homologues. , 2005, Bioorganic & medicinal chemistry.
[14] W. Denny,et al. Acridine derivatives as chemotherapeutic agents. , 2002, Current medicinal chemistry.
[15] A. Osuna,et al. Activity and mode of action of acridine compounds against Leishmania donovani , 1996, Antimicrobial agents and chemotherapy.
[16] Scott D. Kahn,et al. Current Status of Methods for Defining the Applicability Domain of (Quantitative) Structure-Activity Relationships , 2005, Alternatives to laboratory animals : ATLA.
[17] J. Galy,et al. Synthesis and antileishmanial activity of 6-mono-substituted and 3,6-di-substituted acridines obtained by acylation of proflavine. , 2007, European journal of medicinal chemistry.
[18] J. Dearden. The History and Development of Quantitative Structure-Activity Relationships (QSARs) , 2016 .
[19] J. Barbosa-Filho,et al. A review of natural products with antileishmanial activity. , 2005, Phytomedicine : international journal of phytotherapy and phytopharmacology.
[20] Suman Gupta,et al. Synthesis of marine alkaloid: 8,9-dihydrocoscinamide B and its analogues as Novel class of antileishmanial agents. , 2007, Bioorganic & medicinal chemistry letters.
[21] E. Pugh,et al. An Emerging Peri-Urban Pattern of Infection with Leishmania chagasi, the Protozoan Causing Visceral Leishmaniasis in Northeast Brazil , 2004, Scandinavian journal of infectious diseases.
[22] P. Desjeux. The increase in risk factors for leishmaniasis worldwide. , 2001, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[23] S. Croft,et al. Natural Products as potential antiparasitic drugs. , 2002 .
[24] J. Dearden,et al. How not to develop a quantitative structure–activity or structure–property relationship (QSAR/QSPR) , 2009, SAR and QSAR in environmental research.
[25] J. Galy,et al. In Vitro Activities of 7-Substituted 9-Chloro and 9-Amino-2-Methoxyacridines and Their Bis- and Tetra-Acridine Complexes against Leishmania infantum , 2003, Antimicrobial Agents and Chemotherapy.
[26] Gustavo E. A. P. A. Batista,et al. How k-nearest neighbor parameters affect its performance , 2009 .
[27] K. Roy,et al. Be aware of error measures. Further studies on validation of predictive QSAR models , 2016 .
[28] T. Powledge. Is obesity an infectious disease? , 2004, The Lancet. Infectious diseases.
[29] A. Tropsha,et al. Beware of q2! , 2002, Journal of molecular graphics & modelling.
[30] D. Marks,et al. Use of an additional hydrophobic binding site, the Z site, in the rational drug design of a new class of stronger trypanothione reductase inhibitor, quaternary alkylammonium phenothiazines. , 2000, Journal of medicinal chemistry.
[31] David E. Booth,et al. Chemometrics: Data Analysis for the Laboratory and Chemical Plant , 2004, Technometrics.
[32] B. Tekwani,et al. Antileishmanial, antiplasmodial and cytotoxic activities of 12,16‐dideoxy aegyptinone B from Zhumeria majdae Rech.f. & Wendelbo , 2008, Phytotherapy research : PTR.
[33] M. Yadav,et al. Antileishmanial Agents: An Updated Review , 2011 .